carbostyril has been researched along with Adenocarcinoma, Clear Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, K; Eguchi, S; Fujii, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M | 1 |
1 other study(ies) available for carbostyril and Adenocarcinoma, Clear Cell
| Article | Year |
|---|---|
Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro.
Topics: Adenocarcinoma, Clear Cell; Aminooxyacetic Acid; Cell Culture Techniques; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Enzyme Inhibitors; Female; Focal Adhesion Kinase 1; Glutamine; Humans; Ovarian Neoplasms; Phosphorylation; Quinolones; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Spheroids, Cellular; Sulfones; TOR Serine-Threonine Kinases; Transaminases | 2017 |